Protein structure acts as a general constraint on the evolution of viral proteins. One widely recognized structural constraint explaining evolutionary variation among sites is the relative solvent accessibility (RSA) of residues in the folded protein. In influenza virus, the distance from functional sites has been found to explain an additional portion of the evolutionary variation in the external antigenic proteins. However, to what extent RSA and distance from a reference site in the protein can be used more generally to explain protein adaptation in other viruses and in the different proteins of any given virus remains an open question. To address this question, we have carried out an analysis of the distribution and structural predictors of site-wise dN/dS in HIV-1. Our results indicate that the distribution of dN/dS in HIV follows a smooth gamma distribution, with no special enrichment or depletion of sites with dN/dS at or above one. The variation in dN/dS can be partially explained by RSA and distance from a reference site in the protein, but these structural constraints do not act uniformly among the different HIV-1 proteins. Structural constraints are highly predictive in just one of the three enzymes and one of three structural proteins in HIV-1. For these two proteins, the protease enzyme and the gp120 structural protein, structure explains between 30 and 40% of the variation in dN/dS. Finally, for the gp120 protein of the receptor-binding complex, we also find that glycosylation sites explain just 2% of the variation in dN/dS and do not explain gp120 evolution independently of either RSA or distance from the apical surface.
Protein structure acts as a general constraint on the evolution of viral proteins. One widely recognized structural constraint explaining evolutionary variation among sites is the relative solvent accessibility (RSA) of residues in the folded protein. In influenza virus, the distance from functional sites has been found to explain an additional portion of the evolutionary variation in the external antigenic proteins. However, to what extent RSA and distance from a reference site in the protein can be used more generally to explain protein adaptation in other viruses and in the different proteins of any given virus remains an open question. To address this question, we have carried out an analysis of the distribution and structural predictors of site-wise dN/dS in HIV-1. Our results indicate that the distribution of dN/dS in HIV follows a smooth gamma distribution, with no special enrichment or depletion of sites with dN/dS at or above one. The variation in dN/dS can be partially explained by RSA and distance from a reference site in the protein, but these structural constraints do not act uniformly among the different HIV-1 proteins. Structural constraints are highly predictive in just one of the three enzymes and one of three structural proteins in HIV-1. For these two proteins, the protease enzyme and the gp120 structural protein, structure explains between 30 and 40% of the variation in dN/dS. Finally, for the gp120 protein of the receptor-binding complex, we also find that glycosylation sites explain just 2% of the variation in dN/dS and do not explain gp120 evolution independently of either RSA or distance from the apical surface.
Introduction
HIV-1 remains a major public health threat, despite the development of dozens of antiretrovirals, decades of vaccine research and billions spent to halt the virus's transmission. A major challenge in combating the HIV epidemic lies in the virus's ability to adapt to even the most complex, combined therapeutic schedules. Such a high level of adaptability stems from the fact that HIV is among the most rapidly mutating human viruses, it maintains a large intra-patient population size and has a very high replication rate [1] [2] [3] [4] [5] [6] [7] . The development of new vaccines and therapeutics is further complicated by an incomplete understanding of the specific important selection pressures in HIV, the strength of those pressures and the viral proteins that are adapting most rapidly.
There is evidence in at least one HIV-1 gene (env) that evolution occurs through a number of possible mechanisms that might suggest various patterns of evolution of the receptor-binding protein; one such hypothesis is the glycan shield model, whereby the virus shifts glycosylation patterns to block antibody binding directly [4] . Such a constraint could produce a pattern of site-wise dN/dS estimates that are highly predictable with just a single category of likely glycosylation sites. (dN/dS represents the ratio of the rate of non-synonymous substitutions per non-synonymous site, dN, and the rate of synonymous substitutions per synonymous site, dS.) Although there is some evidence that the glycan shield hypothesis does not play out in sequence evolution [2] , beyond the env gene relatively little is known about the pattern of site-wise positive and negative selection in HIV proteins. It may be the case that HIV proteins generally evolve by similar constraints (e.g. protein fold preservation) to eukaryotic proteins. Several such constraints have been described previously by many groups. For example, the relative solvent accessibility (RSA), which measures the extent to which amino acid side chains are exposed on the surface of the protein or buried within the protein structure, has been shown to predict site-wise evolution in eukaryotes [8, 9] , bacteria [10] and some viral proteins [11] . Similar structural constraints like the weighted contact number (WCN), the linear packing density and the mechanistic stress of a site have been described for a large enzyme dataset [12 -15] . These constraints all quantify the extent to which individual amino acids interact with other amino acids in the protein. For a recent review of structural determinants of protein evolution, see Sikosek & Chan [16] .
In addition to uniform structural constraints, the distance from functional sites has been shown to predict a significant portion of evolution in influenza haemagglutinin [17, 18] and neuraminidase [19] . Whether similar distance constraints exist in proteins not expressed on the viral surface, or in a virus that causes persistent infections, is not known. To address these questions, here we carry out a systematic analysis of the structural constraints acting on the evolution of HIV proteins. It may be that constraints such as RSA or distance from a functional surface do not at all constrain the evolution of a retrovirus causing persistent infections or in proteins that are not generally immune-exposed. Further, if these constraints are important for HIV evolution, they may not act uniformly in all HIV proteins.
Results

HIV proteins and structural predictors of evolution
The HIV genome encodes 15 proteins that can be divided into three general categories. The first, the enzymes, are all encoded by the pol gene which encodes three separate proteins. They are, in order of their reference genome numbering, protease, reverse transcriptase (including the RNase H domain) and integrase. Each of these three enzymes assumes a homo-dimeric quaternary structure and all three have clinically available inhibitory drugs. The second category of proteins encoded by the HIV genome are the structural proteins; they are encoded by two different genes in HIV. The matrix, capsid and nucleocapsid are thought to be purely structural and are encoded by the gag gene. The external glycoprotein (gp120) and transmembrane glycoprotein (gp41) are encoded by the env gene and serve the receptor-binding and uptake functions for the virus. The third category of HIV proteins carry out a disparate mix of accessory and regulatory functions for the virus. These include vpu, vif, vpr, p6, nef, rev and tat. For this study, we focus on the enzymes and structural proteins. Specifically, we analyse sequence data and structures for protease, reverse transcriptase, integrase, the matrix and capsid proteins, as well as the apical portion of the ectodomain of the spike glycoprotein, gp120. For each of these proteins, we analyse to what extent metrics taken entirely from the protein's structure can predict the evolution of the protein's sequence, as quantified by the per-site dN/dS metric.
As our baseline evolutionary predictor, we use the RSA. It is possible to calculate RSA in any of several different conformational states. Most simply, one could ignore the higher order quaternary structure of protein complexes and measure RSA on each monomeric unit. Alternatively, one could generate ever more complex multimeric assemblies on which to calculate RSA. Here, we use the minimal multimeric state (called the biological assembly in the protein databank), which has been shown to be the strongest extensible predictor of dN/dS in influenza [17, 18] .
In addition to RSA, we use distance to a single reference point in the protein structure to predict dN/dS. This approach has previously proved effective at identifying regions of possible functional importance in influenza virus [18] . We generate a set of distances using the pairwise distance from each C-alpha atom to every other C-alpha atom in the protein. Then, we perform a cross-validation analysis to identify the best reference point in each protein while controlling for RSA and the risk of over-fitting.
Site-wise dN/dS is gamma distributed in all HIV proteins considered
Many of the models that are commonly used to calculate sitewise dN/dS make underlying assumptions about the distribution of these rates. For example, the widely used M8 model of PAML [20] posits a beta distribution of dN/dS values between 0 and 1 plus one additional rate category to capture sites with dN/dS . 1. Here, instead, we estimate site-wise dN/dS via the fixed-effects-likelihood (FEL) approach [21] . This approach produces dN/dS estimates at each site without imposing any particular distribution on the dN/dS values. Thus, we can use the estimated dN/dS values to ask whether, if at all, they follow any particular distribution. For all of the HIV proteins considered here, we find that dN/dS follows a smooth and continuous distribution, extending out to dN/dS values of about 3 (figure 1). The mean dN/dS over all sites in each protein ranges from 0.19 to 0.78 (table 1) , and all proteins have some fraction of sites with dN/dS . 1. The dN/dS distributions for each protein are well described by gamma distributions with shape parameters between 0.21 and 0.60 and rate parameters between 0.27 and 1.1 (table 2) . In all cases, a x 2 goodnessof-fit test shows no evidence that a gamma distribution is insufficient to describe the observed rate variation (table 2) . By contrast, a beta distribution generally fits less well than a gamma distribution, and for gp120 and reverse transcriptase the beta distribution is actually insufficient to describe the observed dN/dS distribution (table 2) . Importantly, we find no group of sites that are categorically evolving in a 'neutral' or positively selected manner, as would have been evidenced by a peak or discontinuity around dN/dS ¼ 1, or more generally by systematic deviations from the unimodal gamma distribution around or above dN/dS ¼ 1.
In the following subsections, we discuss the evolution of each of the six proteins in more detail.
Evolution of the HIV capsid
The capsid protein is a functional homo-hexamer with extensive contacts to adjacent monomeric units. The hexameric biological assemblies form the basic building blocks for constructing the entire superstructure of the viral capsid.
We find that no part of the capsid protein appears to be under particularly strong evolutionary pressure. With a whole-gene dN/dS ¼ 0.2 (table 1), the capsid has the second lowest rate of adaptation among the proteins we have studied; also, the distribution of dN/dS shows almost no positively selected sites ( figure 1 ). The combined RSA-Distance model predicts less than 10% of the variation in dN/dS. The sites with the highest predicted rate of adaption are near the N-terminal region of the protein, and the sites with the lowest predicted rate of adaptation are near the C-terminal end (figure 2). The distance to sites nearest the N-terminal region of the monomeric protein shows the highest positive predictive power for dN/dS (figure 2b); therefore, sites nearest the N-terminal region of the capsid are, on average, under the strongest pressure from structural constraints.
Evolution of the HIV gp120 protein
The HIV receptor-binding complex is made up of an ectodomain as well as transmembrane and intracellular segments. The ectodomain consists of a homo-trimer of hetero-dimers where each of the dimers consists of a gp120 and a gp41 protein. The gp120 protein serves as the apical segment and the gp41 protein serves as the basal segment. Thus, gp120 is farthest from the viral surface and the HIV protein most exposed to the host immune system. The apical solvent-exposed surface of the gp120 protein appears to be under intense adaptive pressure. With a whole-gene dN/dS ¼ 0.8 (table 1), gp120 has the highest rate of adaptation in HIV and a large number of sites with dN/dS . 1 (figure 1b). Solvent exposure alone accounts for a large fraction of the adaptive evolution (R 2 ¼ 0.18). Nevertheless, adding a single distance constraint to the model roughly doubles the variation explained (table 1) . Where the RSA-only model produces a relatively uniform rate prediction over the entire surface of gp120, adding the set of distances to the linear model orients the elevated dN/dS predictions towards the apical surface of the protein (figure 3a). When taking into account the effect of gp120 glycosylations on selection, we find that, even though glycosylation sites alone are able to predict a small amount of adaptive evolution in gp120, adding glycosylation sites to any single predictor model does not improve or change the overall rate predictions (R 2 :
This finding might be expected since glycosylation sites are on the protein surface. Thus, RSA, and not specific glycosylation sites, captures the most systematic adaptive pressure to gp120 (figure 3b).
Finally, as can be expected from the predicted dN/dS values (figure 3a,b), we find that the sites whose distances provide the highest positive predictive power are located on the apical surface of the ectodomain (figure 3c). Therefore, sites near the surface of the protein and oriented farthest away from the viral surface are on average under the strongest adaptive pressure. Also, no clear connection exists between the glycosylation pattern and the surface with maximum adaptive pressure (figure 3d ).
Evolution of the HIV matrix
The fundamental biological assembly of the HIV matrix consists of homo-trimers of the matrix protein. Unlike the other structural proteins (the capsid and the gp120 protein), the matrix protein has a relatively small contact surface with adjacent subunits.
The matrix displays a relatively high whole-gene dN/ dS ¼ 0.5 (table 1) and a large number of sites with dN/ dS . 1 (figure 1c). Nevertheless, despite the differences in structure, shape and whole-gene dN/dS between the matrix and capsid proteins, our RSA -Distance combined models perform nearly identically for the capsid and the matrix. The validated combined model for the matrix protein explains approximately 9.9% of the variation in dN/dS, compared to 9.2% for the capsid. Also, as is the case for the capsid, there appears to be no region that is under uniformly strong selective pressure (figure 4a), and the cluster of sites with the highest pressure are on the long eccentric arms of the trimer (figure 4b).
Evolution of the HIV integrase
The available structures of integrase show it as a symmetric homo-dimeric structure with long arms protruding from the interaction surface. No structural predictors provide a statistically significant model of integrase evolution (Material and methods and table 1). In addition, integrase has the lowest rate of adaptive evolution and a very small number of sites with dN/dS . 1 (figure 1d).
Evolution of the HIV protease
The protease forms a heart-shaped homo-dimer. The catalytic site of the complex lies in the interface between the two subunits. The protease has a low average dN/dS (table 1) and a very small number of sites with dN/dS . 1 (figure 1e). For functional reasons, the enzyme active site must be accessible, and the protein -protein binding region must maintain a Table 1 . Sequence variation and predictive power of structural models. For each protein, we show the mean pairwise sequence identity in the protein alignment, the mean dN/dS and the R 2 values of all fitted models. The relatively high solvent exposure (figure 5) compared to other protein -protein interfaces. As a result, we expect the highly solvent-exposed catalytic site to cause an RSA-only model to perform poorly. Indeed, RSA alone explains only 4.7% of the variation in dN/dS. However, adding distance produces the second best model among the six proteins tested (table 1) . The dN/dS predictions with the combined RSA -Distance model show that the catalytic site of protease is very conserved relative to the exterior regions of the protein (figure 5a), a finding that would have been impossible to capture without the distance predictor. Moreover, as with the gp120 protein, the pattern of predicted rates is almost perfectly recapitulated by the correlation map (figure 5b).
Evolution of the HIV reverse transcriptase
As with the other HIV enzymes, reverse transcriptase has a relatively low average rate of adaptation at dN/dS ¼ 0.25 (table 1) and very few sites with dN/dS . 1 (figure 1f ). The reverse transcriptase protein is structurally unique among the proteins in HIV. Although it forms a homo-dimeric quaternary structure, the two proteins in the functional assembly do not form the same tertiary structure. In addition, one of the two subunits in the functional assembly retains a separate catalytic domain known as RNase H. The unusual fact that the reverse transcriptase quaternary structure is composed of two identical polymers with RMSD . 4.5 Å between their structures means that any structural model is likely doomed to failure. Despite this fact, we find that the RSA of the first chain alone is a weak, but statistically significant predictor of dN/dS (table 1) . The weakness of the model is highlighted by the fact that the site-wise dN/dS predictions show no clear trend towards important regions of the protein (figure 6a,b). For example, the region contacting nucleic acid does not appear to be particularly well conserved. Also, no set of distances from the first chain adds any predictive power, and strangely the RNase H domain appears to be strongly conserved relative to the nucleic acid contact site of the polymerase (figure 6c,d).
Summary of combined models of HIV evolution
In summary, we find that using RSA in a single predictor model performs poorly in the majority of HIV proteins (figure 7 and table 1). With the exception of gp120, RSA predicts approximately 6% of the variation in dN/dS. This is in contrast to influenza, where RSA explains greater than 10% of the variation in both the haemagglutinin and neuraminidase proteins [17] . In addition, for the integrase protein, RSA is not even a statistically significant predictor of dN/dS; that makes integrase one of a very small number of proteins among the many hundred that have been tested to not display any folding-related evolutionary constraint. For the other five proteins, dN/dS is at least partly predicted by RSA.
Adding the distance to a reference point improves predictions of dN/dS in all of the proteins tested. On average, the models that include distance are able to account for nearly twice as much variation in dN/dS on the test dataset than do models with RSA alone. Importantly, our cross-validated test sets show very similar R 2 values to those from the training set (figure 7 and table 1). Therefore, our optimization scheme is likely not over-fitting the dN/dS data. Also, for each protein, there appears to be a connection between the strength of the initial model that included only RSA and goodness-of-fit test of the fitted distribution to the data. A p-value less than 0.05 indicates that the distribution is not a good fit for the data. Since for all fits of gamma p . 0.1 and in all but one case the gamma p-value is greater than the beta p-value, the gamma distribution fits the observed data objectively well and generally better than beta. protein the RSA-only model and the RSA-Distance model to not be significant. For example, the RSA-only model for protease is the fourth best (third worst) of the six proteins considered, but it becomes the second best model once a distance predictor is added. By contrast, the RSA-only model for reverse transcriptase is virtually identical in predictive power to that of protease; however, the addition of distance does not provide even a minimally significant improvement in dN/dS predictions. There are at least two possible reasons why distance to a reference point improves the evolutionary rate ratio predictions. In both cases, it seems likely that functional importance is driving the gradient of rate variation. First, there may be a functional site whose immediately adjacent three-dimensional structure performs a critical function for the virus. One example would be the active site of the protease. Residues immediately adjacent to the active site will experience some amount of purifying selection, and residues further removed will experience increasingly less purifying selection as they are increasingly uncoupled from the active site. Second, there may be a protein region that is critical for establishing the life cycle, and whose blockage, in particular by antibodies, can break the cycle. The primary example would be the viral spike protein gp120, where blocking the binding surface prevents viral infection. In this case, rather than having purifying selection driving the rate gradient, the virus here is under pressure to rapidly adapt to external selection pressure. To the extent that residues are farther removed from the region under external selection pressure, their utility for adaptation declines and a rate gradient arises.
Discussion
In this study, we have surveyed the distribution and the structural predictors of dN/dS in HIV-1. We have found that all six of the proteins considered display a smooth gamma distribution of dN/dS values; there is no indication of discrete rate categories in the distribution. In addition, we have found that the common structural predictors used in other viruses show mixed results for HIV. The structural predictors RSA and distance work well only in one of the structural proteins (gp120) and one of the enzymes ( protease). The models generated for those two proteins explain between 30 and 40% of dN/dS. In three more proteins (capsid, matrix and reverse transcriptase), RSA and/or distance are significant but weak predictors of dN/dS, explaining 5 -10% of the variation. We have found that glycosylations in the gp120 protein do not predict evolution better than a simple geometric model containing RSA and/or distance from the apical surface. Finally, we have shown, using a very conservative crossvalidation scheme, that adding distance from an optimized reference point to the model significantly improves evolutionary predictions relative to an RSA-only model in the majority of HIV proteins.
A number of structure-based predictors of site-specific evolutionary rate (usually calculated as per-site dN/dS [21] or via Rate4Site [22] ) have been described previously [8,10 -16,23,24] ; the most common ones are the RSA and the WCN. Both of these quantities provide statistically significant predictions of evolutionary rate in other viral systems [11, 18] and in enzymes [12] . Generally, WCN calculated on the amino acid side chain is a stronger predictor of evolutionary rate than RSA calculated in either the monomeric or functional multimeric state [14] . However, for several viral proteins, RSA is a better predictor of rate than WCN [11] , and RSA has been used successfully to model site-specific dN/dS in influenza, in particular in combination with a distance metric [17, 18] . Therefore, we have used RSA as our baseline constraint throughout this work.
A priori, it is not clear that the structural constraints identified in influenza proteins or in cellular enzymes should be applicable to predict dN/dS in HIV. As a result of its errorprone polymerase reverse transcriptase, HIV is among the most rapidly mutating and evolving viruses in nature. Moreover, compared to influenza, it has a very different life cycle, integrating into the host genome and causing long-term persistent infections in patients. For these reasons, it could be the (a) Predicted dN/dS using the RSA -Distance combined model with the best reference point plotted onto the capsid structure. Sites that are red are predicted to be evolving more rapidly and those in blue are predicted to be evolving more slowly. (b) The strength of the correlation between the empirical dN/dS values and the combined RSA -Distance model, using each site in turn as a reference point and plotting the correlation coefficient onto the capsid structure. Red colours represent reference points where distances from that point generate strongest negative predictive models and are on average experiencing more rapid evolution; thus, the redder a site is, the higher its dN/dS value and lower distances from that site are predictive of higher dN/dS values. Blue colours represent reference points with strongest positive predictive models and are on average experiencing slower evolution. The N-terminal end of the protein is noted with an 'N' and the C-terminal end of the protein is noted with a 'C'. rsif.royalsocietypublishing.org J. R. Soc. Interface 12: 20150579 case that the rapid accumulation of unfixed mutations leads to uninformative sequence data or that folding and functional constraints get washed out by a large number of sites under positive selection. We have found, however, that neither of these possibilities is systematically true. Structural constraints predict some amount of the variation in dN/dS in five of six HIV proteins. And for gp120 and protease, combined models of RSA and distance describe the variation in dN/dS values quite well. However, the extent to which distance or RSA predicts evolution differs substantially in these two proteins. In gp120, both predictors account for approximately the same proportion of dN/dS, whereas in the protease, RSA has little value as a predictor. It appears that the primary evolutionary constraint for the protease is the relative biophysical coupling of a residue to the enzymatic active site.
Of the six proteins we have tested, gp120 evolution can be predicted the best by both RSA and distance. This finding is consistent with the protein's function, since viral binding proteins are reliably under significant pressure from the host immune system and perform among the most critical functions for viral survival. We have previously found a similarly predictive model of evolution for influenza haemagglutinin [18] , which performs largely the same function as gp120. Moreover, the gradient of adaptive pressure is oriented in exactly the same direction in gp120 and in influenza haemagglutinin; the apical surface of both proteins is under intense adaptive pressure. Surprisingly, RSA and distance predict a significantly larger portion of the evolution in gp120 than in influenza haemagglutinin. In addition, the small amount of variation in dN/dS that can be accounted for by the category of glycosylation sites is completely obliterated by controlling for either RSA or distance or both. Therefore, contrary to the glycan shield hypothesis [4] , it appears glycosylation status is not a systematic driver of site-wise adaptation in HIV. This result is in line with what has been shown previously from sequence analysis [2] . Figure 3 . Maps of the gp120 protein. The volume is the surface plot of the entire trimeric gp120/gp41 ecto domain of the HIV receptor-binding complex; a gp120 monomer is shown in cartoon. (a,b) Predicted dN/dS using the RSA -Distance combined model with the best reference point plotted onto the gp120 structure. Sites that are red are predicted to be evolving more rapidly and those in blue are predicted to be evolving more slowly. In (b), we add glycosylations to the structure. (c,d ) The strength of the correlation between the empirical dN/dS values and the combined RSA-Distance model, using each site in turn as a reference point and plotting the correlation coefficient onto the gp120 structure. Red colours represent reference points where distances from that point generate strongest negative predictive models and are on average experiencing more rapid evolution; thus, the redder a site is the higher its dN/dS value and lower distances from that site are predictive of higher dN/dS values. Blue colours represent reference points with strongest positive predictive models and are on average experiencing slower evolution. The N-terminal end of the protein is noted with an 'N' and the C-terminal end of the protein is noted with a 'C'.
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The one HIV protein with no apparent structural predictors of dN/dS is the integrase. This result remains irrespective of which domains are included in the analysis and of how complete the structural model is made (see Material and methods for details). Integrase is thus one of a small number of proteins for which no structural constraints on sequence divergence are known. There are a number of possible explanations for this finding. First, considering the historical difficulty of crystallizing the HIV-1 integrase, it may be that the protein spends most of its time in a relatively disordered state. Such a situation would necessarily reduce the pressure to be folded and reduce-at a minimumthe RSA constraint. Second, since no full-length structures exist that were generated in a single experiment, it is possible that all of the partial structures that are available to us miss a significant portion of the correct protein contacts. Third, it is also possible that the available crystal structures are simply not capturing any real physiological state. Fourth, some combination of these issues may be at play. For example, if the protein is frequently disordered, it may be relatively easy for the protein to be contorted into non-physiological states during crystallization.
Even for the protein whose dN/dS values are best described by structural predictors, the gp120 protein, the correlations we have observed are relatively modest, and less than 40% of the variance in dN/dS is explained by our structural model. And for most of the other HIV proteins we have analysed, predictions are much weaker. There are at least two factors that may limit the predictive power of our models: first, the accuracy of dN/dS estimates depends on the overall amount of sequence divergence in the dataset, and dN/dS estimates from individuals in a single, rapidly The strength of the correlation between the empirical dN/dS values and the combined RSA -Distance model, using each site in turn as a reference point and plotting the correlation coefficient onto the matrix structure. Red colours represent reference points where distances from that point generate strongest negative predictive models and are on average experiencing more rapid evolution; thus, the redder a site is, the higher its dN/dS value and lower distances from that site are predictive of higher dN/dS values. Blue colours represent reference points with strongest positive predictive models and are on average experiencing slower evolution. The N-terminal end of the protein is noted with an 'N' and the C-terminal end of the protein is noted with a 'C'. (a) Predicted dN/dS using the RSA -Distance combined model with the best reference point plotted onto the protease structure. Sites that are red are predicted to be evolving more rapidly and those in blue are predicted to be evolving more slowly. (b) The strength of the correlation between the empirical dN/dS values and the combined RSA -Distance model, using each site in turn as a reference point and plotting the correlation coefficient onto the protease structure. Red colours represent reference points where distances from that point generate strongest negative predictive models and are on average experiencing more rapid evolution; thus, the redder a site is, the higher its dN/dS value and lower distances from that site are predictive of higher dN/dS values. Blue colours represent reference points with strongest positive predictive models and are on average experiencing slower evolution. The N-terminal end of the protein is noted with an 'N' and the C-terminal end of the protein is noted with a 'C'. rsif.royalsocietypublishing.org J. R. Soc. Interface 12: 20150579 evolving viral population are inherently noisy and somewhat unreliable [25, 26] . Indeed, correlations between structural predictors and site-wise evolutionary rates tend to be systematically lower in analyses of single viral populations than in analyses of cellular proteins taken from widely diverged species [11] . Second, viral proteins may have structural features that make structural predictors of sequence variation less reliable. In particular, it has been suggested that viral proteins are less densely packed than cellular proteins and display significant local disorder [27] . These structural features may be crucial for the high-mutation-rate, rapidly changing environment viruses commonly experience, but they will make prediction of rate variation from structure more difficult.
We have found across the board that the distribution of site-wise dN/dS is always continuous, and a continuous gamma distribution describes dN/dS variation more accurately than does a beta distribution (table 2). We considered these distributions because they are commonly used in molecular evolution analyses, and the beta plus one model is the basis of the M8 model widely used for positive-selection inference. Our results suggest that, at least in HIV proteins, gamma is preferable to beta. However, our results do not rule out that another distribution might fit the data even better, nor do they provide a mechanistic reason for why dN/dS values are gamma distributed.
Our finding of smoothly gamma-distributed dN/dS values contradicts the long-standing practice in molecular evolution of assigning sites to specific rate categories, in particular for sites with dN/dS . 1 [20,28 -30] . In addition, our results imply that, at least in HIV, any sort of distribution that can model an additional peak near dN/dS ¼ 1 or any attempt to artificially truncate the distribution at dN/dS ¼ 1 (e.g. the b distribution) in order to find sites with dN/dS . 1 is most likely unnecessary to represent the actual variation in dN/dS. Finally, since we have previously made a similar observation for influenza haemagglutinin [19] , we suspect that the gamma distribution may be the typical distribution generated by common structural and functional selection pressures acting on proteins.
A smooth gamma distribution covering dN/dS values both below and above 1 puts into question the practice of placing a hard boundary at dN/dS ¼ 1 and then searching for sites with significantly higher dN/dS. A null model of dN/ dS ¼ 1 is constructed on the assumption that all 20 amino acids are equally probable at every site, an assumption that clearly cannot hold for any realistic protein [31] . Proteincoding sequences generally experience some amount of Figure 6 . Maps of the reverse transcriptase complex. The volume is the surface plot of the entire dimeric reverse transcriptase complex; a reverse transcriptase monomer is shown as a cartoon. (a,b) Predicted dN/dS using the RSA -Distance combined model with the best reference point plotted onto the reverse transcriptase structure. Sites that are red are predicted to be evolving more rapidly and those in blue are predicted to be evolving more slowly. (c,d ) The strength of the correlation between the empirical dN/dS values and the combined RSA-Distance model, using each site in turn as a reference point and plotting the correlation coefficient onto the reverse transcriptase structure. Red colours represent reference points where distances from that point generate strongest negative predictive models and are on average experiencing more rapid evolution; thus, the redder a site is, the higher its dN/dS value and lower distances from that site are predictive of higher dN/dS values. Blue colours represent reference points with strongest positive predictive models and are on average experiencing slower evolution. The N-terminal end of each polypeptide is noted with an 'N' and the C-terminal end of each polypeptide is noted with a 'C'. The single RNase H domain for the complex is also noted.
rsif.royalsocietypublishing.org J. R. Soc. Interface 12: 20150579 purifying selection at most sites, simply because the protein needs to be stably folded to function. And, as our distribution plots show, even in viruses with very high mutation rates, numerous sites under positive selection, and a large number of confounding polymorphisms that likely inflate site-wise estimates, the vast majority of sites have dN/dS , 1. Thus, the neutral expectation in a properly folded protein is likely not dN/dS ¼ 1 but quite a bit lower [17] . Therefore, we cannot really identify a neutral regime per se, and structured proteins likely do not ever evolve entirely neutrally (i.e. with dN/dS ¼ 1) with any regularity. Thus, ideally, we would want to be able to identify the expected dN/dS at a given site under structurally constrained neutral evolution for the given type of protein fold, and then we could test whether that site has an elevated dN/dS relative to that value. If most structured proteins have gamma-distributed site-wise dN/dS values, calculating the probability of observing a particular dN/dS value in a particular protein fold is a simple process. On the flip side, however, testing for dN/dS . 1 is not wrong, it is just very conservative. A site with dN/dS . 1 is not very likely to be a false positive, but several sites with dN/dS , 1 may be false negatives under the traditional tests for positive selection. Whether gamma-distributed dN/dS values are a common feature of most proteins or specific to the particular proteins studied here remains an open question. However, we suspect that this or a similar, continuous unimodal distribution can describe rate variation in most proteins. First, the gamma distribution has a long history of use in phylogenetic inference, and it generally works well [32] . Second, among the six proteins studied here, not a single one showed substantial deviations from the gamma distribution, even though the proteins are all very different in size, shape, function and selection pressures (as evidenced by the large differences in explanatory power of RSA and the distance metric). At present, however, we lack a good mechanistic model explaining why rates are gamma distributed. We suspect that developing such a model will be a fruitful avenue for future research.
Material and methods
Obtaining and preparing HIV gene sequences
Gene sequences were taken from the HIV database at Los Alamos National Laboratory [33] . We exclusively used premade gene alignments. The alignments were assumed to be correct and therefore not changed for any of the genes in this study. There were 2313 sequences for the capsid protein, 1337 sequences for gp120, 1374 sequences for integrase, 2331 sequences for the matrix protein, 1380 sequences for protease and 1281 sequences for reverse transcriptase. To identify the genes in the whole genome sequences, we used the annotation landmarks available in the sequence database. We used only non-recombinant M group sequences. Prior to tree building, the sequences were filtered to include only those with entirely canonical bases. We further changed stop codons in the original alignment to gaps. We used Biopython for all sequence manipulation and clean-up [34] .
Calculating the site-wise evolutionary rate ratio
We built phylogenetic trees with FASTTREE v. 2.1.7 with the following input line [35] : fasttree -nt -gtr -nosupport alignment.fasta. alignment.tree.
In addition, we made minor changes to the FASTTREE source code to prevent rounding errors in the tree branch lengths, as Figure 7 . R 2 value for each of the proteins and models tested in this study. The colours represent the model and dataset that was used for fitting. The red and green bars show results from the combined RSA -Distance model. In red, we show R 2 values from optimized linear models fitted to 75% of the sites; we still include all reference sites, but only 75% of the distances from that site. In green, we show the R 2 value for the 25% of data that was not used for optimization, using the best site from the optimized set. In blue, we show the R 2 value of a model that only uses RSA as a predictor for dN/dS. discussed (http://darlinglab.org/blog/2015/03/23/not-so-fastfasttree.html). Given a codon alignment and evolutionary tree, we used the phylogenetic software HYPHY to calculate the evolutionary rate ratio dN/dS [36] . We used the built-in one-rate FEL method with the default model [37] . The FEL method calculates an independent dN/dS value at each column in the alignment. To calculate a one-rate dN/dS value, the model computes a single dS/dt value for the entire alignment and an individual dN/dt at each site. It then normalizes each dN/dt value by dividing by the average dS/dt to obtain dN/dS.
Obtaining and mapping protein structures
We selected all of the enzymes and all but one of the structural proteins for inclusion in this study; the nucleocapsid structural protein was left out because an enormous portion of its surface is covered by nucleic acid, which makes calculating reliable site-wise RSA difficult. We omitted the class of accessory proteins because most of them are very long and seemingly unstructured, covered by nucleic acid, or covered by various host proteins. In each case, we were sceptical a priori that typical structural determinants could be easily applied to those proteins.
Protein structures were obtained from the RCSB Protein Databank (PDB) [38] . For each of the six proteins, we obtained both the monomeric structure and, if quaternary structure was functionally important, the full biological assembly. This study included all three of the enzymes encoded by the HIV pol gene: reverse transcriptase (PDBID: 1HYS [39] ), integrase (PDBID: 1EX4 and 1K6Y [40, 41] ) and protease (PDBID: 1HPV [42] ). In addition, we included the three HIV structural proteins that do not bind nucleic acid. Those include the capsid ( p24, PDBID: 3H47 [43] ), the matrix ( p17, PDBID: 1HIW [44] ) and the major component of the HIV receptor-binding protein (gp120, PDBID: 4TVP [45] ). When choosing PDB structures for analysis, we broadly followed the HIV structure suggestions curated by the PDB.
Integrase constituted a special case as it lacked a full-length structure from a single experiment and it was the protein that showed no structural predictors. As a result, we tried a number of different structures to find structural predictors. We first tried the 1EX4 structure alone; this structure includes the C-terminal domain but lacks the N-terminal region. In addition, we tried using the 1K6Y structure alone which includes the N-terminal region but lacks a portion of the C-terminal domain. Then, in an attempt to have a full-length model, we aligned the centre structural domain of 1EX4 with that of 1K6Y. Fortunately, there is a relatively large gap from site 46 to site 56 in the N-terminal domain of 1K6Y and the central domains of the two structures align with RMSD ¼ 0.686. Therefore, the cores of the two proteins align almost perfectly making it possible to simply translate and add the coordinates of the N-terminal domain atoms from 1K6Y to the more complete 1EX4 structure. This procedure produced a nearly full-length model of integrase that was used for further analysis.
To map protein structures onto the existing alignment, we used a recent development version of the sequence alignment software MAFFT [46] [47] [48] . This version included the ability to add a sequence to an existing alignment while removing any sites where there was an insertion in the protein-structure sequence. We used the following input line: mafft --mapout --addfragments aas.fasta alignment.fasta . added_ alignment.fasta
Calculating structural predictors
We used two independent structural predictors from the protein structures. The first was RSA which has been detailed extensively previously [9, 17, 18, 49] . We used the program DSSP to compute the absolute solvent accessibilities of each residue in the protein [50] . Then, we used maximum absolute accessibility values for each residue to normalize solvent exposure to a value between 0 and 1 [51] . For all models in this study, we used the RSA of a chain in the functional multimeric state of the biological assembly.
The second metric was distance to a reference point [18, 19] . To compute the set of distances, we used each C-alpha atom in the protein as a reference point and calculated the distance to every other C-alpha. Thus, the distances from a single C-alpha atom to every other C-alpha atom constituted a single distance set. We repeated this calculation using every amino acid to generate a symmetric matrix of distances. In this matrix, the diagonal is always zero as it is simply the distance from an amino acid to itself. One minor change since Meyer & Wilke [18] and Meyer et al. [19] is the use of distances rather than inverse distances. Distance was used because the cross-validation scheme indicated that inverse distance may be over-fitting some of the proteins in HIV. We did, however, invert the colours on the structural maps such that redder colours still mean higher dN/dS. This was done in an effort to maintain the intuitiveness of a warm colours. For gp120, we included glycosylation sites as a categorical predictor. To find sites covered by sugar moieties, we used the glycosylations found in the 4TVP structure to calculate all amino acid sites that were within four angstroms of any sugar atom. Then, we included the set of these sites as a predictor in the linear models below.
Constructing linear models and cross-validation
It has been shown previously that RSA is a relatively strong structural predictor for site-wise dN/dS both in viruses and in cellular proteins. Thus, for each protein, we started with a linear model that predicted site-wise dN/dS from site-wise RSA. We generated the initial models for each protein as
where b 1 and b 0 are the slope and the intercept of the linear model, respectively. The R 2 value of this model for each protein is shown in table 1.
To find the best reference point among the entire set of possible reference points, we next constructed combined linear models using both RSA and the distance from one single reference site as predictors. We generated each of these combined models as
where again b i are the regression coefficients and Distance i is the distance from reference site i to all other sites in the protein.
Thus, there was one model for each reference site i in the protein.
The dN/dS and RSA values, however, were the same in each model, while the set of distances changed for each site. To guard against over-fitting, we trained the model on a randomly chosen 75% of the sites and reserved 25% for validation of the best reference point found in the training set. Thus, the work flow for a single protein involved the following:
(1) Choose a reference site i. this value (or more precisely, its average calculated under
Step 6) is used to colour site i in the protein-structure visualizations. (6) Repeat Steps 2 -5 for 100 times and calculate the average correlation coefficient observed under Step 5. (7) Repeat from Step 1 for the next reference site.
We emphasize that we iterated this algorithm over all possible reference sites i, but for each individual one we only used dN/dS, RSA and distances for 75% of the sites for model fitting (Step 2).
Finally, for each protein, we used the site that was found most frequently during training as the best site for the final prediction. All of our models and figures were generated in the statistical language R using the ggplot2 package [52, 53] .
